1. Catalogs
  2. Pancom
  3. ANT IGEN C O V ID R A P ID T E S T

ANT IGEN C O V ID R A P ID T E S T

ANT IGEN C O V ID R A P ID T E S T

ANT IGEN C O V ID R A P ID T E S T

Product catalog summary
Product Overview: The document describes a COVID-19 Antigen Rapid Test designed for fast diagnosis with a detection time of 15 minutes using a swab sample from the throat and/or nose. The test is easy to use, affordable, and does not require any device, boasting a sensitivity of 97.59% and specificity of 98.43%.
Usage Procedure: The test involves three main steps: 1) Sample Collection using oropharyngeal or nasal swabs, 2) Preparation by applying the extracted sample, and 3) Identification by reading the test result.
Benefits: The test is easy to use, accessible, affordable, and portable. It provides early detection and fast diagnosis without the need for additional devices.
Result Interpretation: The test results can be positive, negative, or invalid. A positive result indicates a probable active COVID-19 infection, while a negative result suggests the absence of an active infection.
Technical Examination: The test is a chromatographic immunological-based in vitro test using the lateral flow method. It is designed for the rapid qualitative detection of SARS-CoV-2 virus antigens from nasopharyngeal and/or oropharyngeal swab samples within the first seven days after symptom onset.
Packaging and Distribution: The product is available in various packaging options, including cartons and pallets, with specific dimensions and quantities outlined for distribution.
Contact Information: The headquarters is located in Austria, with a sales office and factory in Istanbul, Turkey. Contact details and website information are provided for further inquiries.
See more

Catalog excerpts

ANT IGEN C O V ID R A P ID T E S T-1

ANTIGEN COVID RAPID TEST

 Open the catalog to page 1
ANT IGEN C O V ID R A P ID T E S T-2

COVID-19 ANTIGEN IN DETECTION FAST DIAGNOSIS TEST

 Open the catalog to page 2
ANT IGEN C O V ID R A P ID T E S T-3

15 MINUTE DETECTION TIME WİTH A SWAB SAMPLE FROM THE THROAT AND/OR NOSE

 Open the catalog to page 3
ANT IGEN C O V ID R A P ID T E S T-4

SAMPLE COLLECTİON OROPHARYNGEAL SWAB PREPARE SAMPLE NASAL SWAB READ THE TEST RESULT APPLY THE EXTRACTED SAMP

 Open the catalog to page 4
ANT IGEN C O V ID R A P ID T E S T-5

ANTİGEN BENEFİTS EASY USE, EASİLY ACCESSİBLE, AFFORDABLE COST, NO DEVİCE REQUİRED, EASY TO CARRY, WİTH 97.59% SENSİTİVİTY AND 98.43% SPECİFİCİTY TRUSTWORTHY. EARLY

 Open the catalog to page 5
ANT IGEN C O V ID R A P ID T E S T-6

FAST DIAGNOSIS TEST OF THE RESULTS INTERPRETATİON POSİTİVE YOU PROBABLY *CURRENTLY HAVE AN ACTİVE COVID-19 İNFECTİON. YOU MOST LİKELY *DO NOT CURRENTLY HAVE AN ACTİVE COVID-19 İNFECTİON. ANTİGEN TEST DIAGNOSIS PROCESS ANTİGEN DETECTİON DİAGNOSTİC TESTS ARE DESİGNED TO DİRECTLY DETECT SARSCOV-2 PROTEİNS, CALLED ANTİGENS, ON THE SURFACE OF THE VİRUS AND ARE CALLED BOTH LABORATORY-BASED TESTS AND RAPİD DİAGNOSTİC TESTS DEVELOPED FOR

 Open the catalog to page 6
ANT IGEN C O V ID R A P ID T E S T-7

TECHNICAL EXAMINATION COVID-19 IVD SOLUTİON LATERAL FLOW METHOD COVID-19 ANTİGEN TEST (SARS-COV-2); IT İS A CHROMATOGRAPHİC İMMUNOLOGİCALBASED İN VİTRO TEST. IT İS DESİGNED FOR THE RAPİD QUALİTATİVE DETECTİON OF SARSCOV-2 VİRUS ANTİGEN WİTH THE AİD OF A NASOPHARYNGEAL AND/OR OROPHARYNGEAL SWAB SAMPLE TAKEN FROM PERSONS WİTH SUSPECTED COVID-19 WİTHİN THE FİRST SEVEN DAYS AFTER SYMPTOM ONSET. LATERAL FLOW METHOD (CRT) LATERAL FLOW METHOD (CRT) NUCLEİC ACİD SAMPLE TYPE NASOPHARYNGEAL, OROPHARYNGEAL SWAB, SPUTUM AND BAL FLUİD SERUM/ PLASMA SERUM/PLASMA / WHOLE BLOOD NASOPHARYNGEAL OROPHARYNGEAL SWAB...

 Open the catalog to page 7
ANT IGEN C O V ID R A P ID T E S T-9

LİECHTENSTEİNER STRASSE 68 AT-6800 FELDKİRCH AUSTRIA HEADQUARTER HALASKARGAZİ MAH. RUMELİ CAD. MATBAACI OSMANBEY SOK NO:36/1 BİLGEHAN D:8 ŞİŞLİ-İSTANBUL-TURKEY SALES OFFICE & FACTORY

 Open the catalog to page 9
*Prices are pre-tax. They exclude delivery charges and customs duties and do not include additional charges for installation or activation options. Prices are indicative only and may vary by country, with changes to the cost of raw materials and exchange rates.